PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Ellen M McDonagh, Sotiria Boukouvala, Eleni Aklillu, David W Hein, Russ B Altman, Teri E Klein

Journal: Pharmacogenetics and genomics 2014;24(8):409-25

PMID: 24892773

Free Full Text on PubMed Central View on PubMed

Abstract

Address: Departments of aGenetics bBioengineering, Stanford University, Palo Alto, California cDepartment of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville, Kentucky, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.

DOI: 10.1097/FPC.0000000000000062

Link outs

Free resources

Full Text Sources:

Other Literature Sources:

Subscription / membership required

Full Text Sources:

MeSH Terms: Alleles, Arylamine N-Acetyltransferase, Caffeine, Gene Expression Profiling, Genomics, Genotype, Humans, Hydralazine, Isoenzymes, Isoniazid, Pharmacogenetics, Phenotype, Polymorphism, Genetic, Sulfamethoxazole, Sulfasalazine, Xenobiotics